Investing.com - Bio-Rad Labs B (NYSE: BIOb) reported first quarter EPS of $3.34, $0.61 worse than the analyst estimate of $3.95. Revenue for the quarter came in at $676.84M versus the consensus estimate of $696.08M.
Bio-Rad Labs B's stock price closed at $467.95. It is up 0% in the last 3 months and down -7.34% in the last 12 months.
Bio-Rad Labs B saw positive EPS revisions and negative EPS revisions in the last 90 days. See Bio-Rad Labs B's stock price’s past reactions to earnings here.
According to InvestingPro, Bio-Rad Labs B's Financial Health score is "good performance".
Check out Bio-Rad Labs B's recent earnings performance, and Bio-Rad Labs B's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar